Login +0086-27-65522453 sales@sun-shinechem.com

Brivaracetam Catalog No : 16122906

Chemical Information

Product NameBrivaracetam
Iupac Chemical NameBrivaracetam 
SynonymsUCB 34714; UCB-34714; UCB34714; Briviact 
Molecular FormulaC11H20N2O2 
Molecular Weight212.293 
SmileCc1nc(cs1)COc2ccc(cc2)C[C@@H]([C@@H](CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)O)NC(=O)O[C@H]5CO[C@@H]6[C@H]5CCO6
InChiKeyJORVRJNILJXMMG-OLNQLETPSA-N
InChiInChI=1S/C33H41N3O10S2/c1-20(2)14-36(48(39,40)25-8-9-29-30(13-25)45-19-44-29)15-28(37)27(35-33(38)46-31-17-43-32-26(31)10-11-41-32)12-22-4-6-24(7-5-22)42-16-23-18-47-21(3)34-23/h4-9,13,18,20,26-28,31-32,37H,10-12,14-17,19H2,1-3H3,(H,35,38)/t26-,27-,28+,31-,32+/m0/s1
Cas357336-20-0
MDLMFCD13152385

Technical Data

Appearancecrystalline solid 
Purity98% 
SolubilitySoluble in DMSO 
Storage3 years -20ºCpowder 
Shipping ConditionShipped under ambient temperature as non-hazardous chemical. 
Quality control

Description

Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties approved for the treatment of epilepsy. Brivaracetam is believed to act by binding to the ubiquitous synaptic vesicle glycoprotein 2A (SV2A), like levetiracetam. SV2A plays a role in exocytosis of various neurotransmitters. Brivaracetam was approved to treat partial-onset seizures with or without secondary generalisation, in combination with other antiepileptic drugs. 

Chemical Structure

16122906 - Brivaracetam | CAS 357336-20-0

Package

SizePrice
Login to get price

Quick Order

Change

Contact Us